HealthDay News — Spinal cord stimulation (SCS) effectively reduces chronic pain symptoms in individuals with painful diabetic polyneuropathy (PDPN), according to a study published online in Diabetes Care.

Maarten van Beek, from Maastricht University Medical Center in the Netherlands, and colleagues performed a prospective multicenter study to examine the long-term effect of SCS on pain ratings, treatment success and failure, and complications in 48 patients with PDPN.

The researchers found that after 5 years, 55% of patients had experienced treatment success and 80% of patients with a permanent implant still used their SCS device.

The median duration of SCS treatment was 60 months. Higher Michigan Diabetic Neuropathy Score was associated with treatment failure during the 5-year follow-up (hazard ratio 3.9).

“SCS is successful in reducing chronic pain symptoms in the lower extremities of patients with PDPN up to 5 years after initiation of treatment,” the authors write.

The study was funded by Medtronic.

Related Articles

Reference

van Beek M, Geurts JW, Slangen R, et al. Severity of neuropathy is associated with long-term spinal cord stimulation outcome in painful diabetic peripheral neuropathy: five-year follow-up of a prospective two-center clinical trial [published online November 6, 2017]. Diabetes Care. doi: 10.2337/dc17-0983